Index of reports
> Cases with Graft Loss (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Nulojix (Belatacept) where reactions include graft loss. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Nulojix side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-13
Patient: 60 year old female, weighing 69.0 kg (151.8 pounds)
Reactions: Disseminated Intravascular Coagulation, Renal Vein Thrombosis, Graft Loss
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Medrol
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-12-27
End date: 2011-12-27
Nulojix
Indication: Renal Transplant
Start date: 2011-12-27
End date: 2011-12-27
Mycophenolate Mofetil (Cellcept)
Dosage: reg 2, 1gm bid, 29dec-29dec11.
Indication: Renal Transplant
Start date: 2011-12-27
End date: 2011-12-29
Campath
Indication: Renal Transplant
Start date: 2011-12-27
End date: 2011-12-27
Other drugs received by patient: Lasix
Possible Nulojix side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-08
Patient: 60 year old female
Reactions: Disseminated Intravascular Coagulation, Renal Vein Thrombosis, Graft Loss
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Nulojix
Indication: Renal Transplant
Start date: 2011-12-27
End date: 2011-12-27
Mycophenolate Mefetil
Start date: 2011-12-27
End date: 2011-12-29
Alemtuzumab
Start date: 2011-12-27
End date: 2011-12-27
Methylprednisolone
Administration route: Oral
Start date: 2011-12-27
End date: 2011-12-27
|